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Emerging and re-emerging viruses continue to surface all over the world. Some of these viruses have the potential for rapid 
and global spread with high morbidity and mortality, such as the SARS coronavirus outbreak. It is extremely urgent and im-
portant to identify a novel virus near-instantaneously to develop an active preventive and/or control strategy. As a culture-      
independent approach, viral metagenomics has been widely used to investigate highly divergent and completely new viruses in 
humans, animals, and even environmental samples in the past decade. A new model of Koch’s postulates, named the meta-
genomic Koch’s postulates, has provided guidance for the study of the pathogenicity of novel viruses. This review explains the 
viral metagenomics strategy for virus discovery and describes viruses discovered in human feces in the past 10 years using this 
approach. This review also addresses issues related to the metagenomic Koch’s postulates and the challenges for virus discov-
ery in the future. 
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In the past decade, several serious emerging viral infectious 
diseases have left deep impression on many people. The 
world witnessed the first pandemic of the new millennium 
in 2003. Instead of the influenza virus, severe acute respira-
tory syndrome coronavirus (SARS-CoV) caused the first 
serious and widespread zoonotic disease, having a huge 
global impact on health, travel, and the economy [1–5]. The 
great global impact of the SARS outbreak was in some 
ways intensified by the delay in identifying the causative 
agent of the disease. Within a few months, SARS-CoV 
caused approximately 916 deaths and affected around 30 
countries. When the novel SARS-CoV was isolated by a 
joint effort of the World Health Organization (WHO) SARS 
Collaborative Network, six months had passed. Hence, 
identifying the causative agent of a new epidemic is one of 
the most important steps for active control and prevention 
of viral disease outbreaks. 
With the development of novel modern molecular bio- 
logy technology, especially sequence-independent single-       
primer amplification (SISPA) [6], next-generation sequenc-
ing (NGS) such as 454-pyrosequencing [7,8], and viral 
metagenomics [9–11], multiple viruses can be detected 
simultaneously, and novel and highly divergent viruses can 
be discovered and genetically characterized quickly. A nov-
el phlebovirus of the Bunyaviridae family, known as severe 
fever with thrombocytopenia syndrome bunyavirus, was 
discovered using SISPA technology [12,13]. Human bo-
cavirus was also identified using the above-mentioned 
methods in 2005 [14]. Recently, a novel coronavirus, 
HCoV-EMC, was isolated in Jeddah, Saudi Arabia on June 
13, 2012 [15]. Subsequently, the complete genome of 
MERS-hCoV was determined using an unbiased virus dis-
covery approach involving NGS techniques, which deter-
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mined that it was closely related to bat coronavirus but was 
distant from SARS-CoV [16]. This novel coronavirus, 
MERS-hCoV, reminds us to pay attention to animal coro-
naviruses, which may be the cause of severe disease in hu-
mans, and to develop strategies to rapidly determine un-
known viral agents [17]. In fact, only limited data are 
available regarding the diversity of viruses present in hu-
mans and animals. A great number of human and animal 
viruses are still unknown. 
1  Traditional methods of virus discovery 
Before the advent of modern molecular methods, traditional 
virus discovery included filtration, tissue culture, electron 
microscopy, serology, and vaccination; cell culture for virus 
propagation was the virus discovery gold standard. Howev-
er, many viruses cannot be easily propagated in cell culture, 
thus limiting our understanding of virology. Two milestone 
findings solved these difficulties, which allowed those in-
terested in understanding new viruses first to amplify and 
then to sequence viral nucleic acids, namely DNA amplifi-
cation by polymerase chain reaction (PCR) [18] and DNA 
sequencing with chain-terminating inhibitors (Sanger se-
quencing or first-generation sequencing) [19]. The number 
of sequences deposited on GenBank between August 2009 
and August 2010 has totaled 970 million and 43 million 
bases of viral and phage origin, respectively, representing 
an annual growth of 20%–24% [20]. After that, several se-
rious emerging viruses, such as Hendravirus [21], Nipah 
virus [22], Menangle virus [23], Melaka virus [24], and 
Reston Ebola virus [25], were discovered in different coun-
tries. The trend in virology research has shown gradual sub-
stitution of the traditional virus discovery methods with novel 
modern molecular biology technology. Nevertheless, tradi-
tional methods to isolate, identify, and characterize viruses 
play complementary roles in the virus discovery effort. 
2  Novel modern molecular techniques of virus 
discovery 
There are two major types of molecular methods for virus 
discovery, including sequence-dependent and sequence-      
independent methods. Sequence-dependent methods require 
knowledge of the nucleic acid sequence. Such methods in-
clude consensus primer PCR and microarrays. Several vi-
ruses, such as human immunodeficiency virus [26], simian 
retroviruses [27–29], and hepatitis E virus [30], have been 
identified using consensus sequences of known viruses; 
however, these methods have little or no value for charac-
terizing completely novel viruses. Microarrays use probes 
that can hybridize to known viral sequences and potentially 
novel viruses with sufficient sequence similarity [31]. Mi-
croarrays have been applied in the detection of swine res-
piratory viruses in clinical samples [32] and for dengue vi-
rus [33]. Unlike sequence-dependent methods, the sequence- 
independent approaches do not rely on any knowledge of 
the virus. SISPA circumvents the viral load limitation of 
suppression subtractive hybridization (SSH). By now, there 
are several variations to the original protocol created by 
Reyes et al. [6]. The main strategy of SISPA is to exploit 
the sensitivity and the specificity of PCR amplification us-
ing primers that bind oligonucleotide fragments ligated to 
any putative viral DNA material in the sample. SISPA has 
been modified to allow the detection of both DNA and RNA 
viruses after the removal of genomic and contaminating 
nucleic acids [34]. Human astrovirus [35] and parvoviruses 
2 and 3 [36] were discovered using SISPA methods. Another 
sequence-independent and culture-independent approach, 
viral metagenomics, provides superior capability for detect-
ing known and unknown viruses and will be described in 
detail below. 
3  Viral metagenomics 
The term ‘metagenome’ was proposed earlier by Handels-
man in PubMed, in 1998, in relation to classifying uncul-
turable bacteria from soil samples [37]. Metagenomics can 
be defined as the characterization of genetic information 
directly from samples. It is a culture- and sequence-inde-     
pendent approach that does not rely on the presence of any 
particular gene in all subject entities [7,10]. This approach 
was originally developed as a tool for ‘functional and se-
quence-based analysis of collective microbial genomes 
contained in environmental samples’ [38,39]. The first ap-
plication of metagenomics to the field of virology was in the 
analysis of viral communities sampled at two near-shore 
marine locations in San Diego, California [40]. Since then, 
viruses in numerous environments, including freshwater, 
marine sediment, soil, and the human gut, were surveyed. 
More information on published environmental viral meta-
genomes, DNA viral families, and RNA viral families in 
environmental samples and organisms found using the viral 
metagenomic approach can be found in Rosario’s review [9]. 
The availability of NGS has forced viral metagenomics to 
be evaluated by unbiased means at previously unforeseen 
resolution and is providing a wealth of new opportunities in 
two major areas: viral candidate pathogen discovery and 
viral ecology [7].  
Currently, several commercially available high-throughput 
sequencing platforms exist that vary by way of their se-
quencing principle, sequencing speed, expense, and read 
length. Figure 1 shows a schematic flow diagram summa-
rizing the viral metagenomic studies that used sequence-      
independent amplification and high-throughput sequencing 
for virus discovery in 2012. A metagenomic analysis essen-
tially entails the following steps: sample preparation, se-
quence-independent amplification, high-throughput sequenc- 
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Figure 1  Overview of viral metagenomic studies in 2012. Viruses discovered through viral metagenomic studies from 2002 to 2011 have been described in 
detail by Mokili et al. [10]. 
 
 
Figure 2  Schematic flow diagram of a typical viral metagenomic study. 
 
ing, and bioinformatics analysis (Figure 2). Below, we 
briefly discuss each step of this viral metagenomic process. 
More detailed descriptions can be obtained in a previously 
published paper [41]. 
(i) Sample preparation.  Theoretically, any type of sam-
ple can be analyzed using the viral metagenomic approach; 
however, viral genomes are relatively short and of low con-
centration in many samples, and bacterial and eukaryotic 
nucleic acids can interfere with the isolation and detection 
of viral DNA or RNA. Thus, one of the most important, yet 
difficult, tasks of viral metagenomics is removal of 
non-viral nucleic acid while preserving viral nucleic acids 
[11,41,42]. Toward this aim, several measures have been 
taken, such as SYBR-gold staining, filtration, sucrose or 
cesium chloride density centrifugation [41], DNase diges-
tion [43], and chloroform treatment [44]. Total RNA con-
tent is usually estimated by measuring ribosomal RNA 
(rRNA), because the abundance of rRNA and its association 
with ribosomes makes the detection of contaminating RNA 
viruses difficult. However, RNases are ineffective for deg-
radation of rRNA. Therefore, other strategies must be em-
ployed. One rRNA depletion strategy is to use random pri-
mers during cDNA synthesis that do not target rRNA se-
quences [45,46]. Another strategy is to use biotin-labeled 
probes that target ribosomal sequences for depletion 
[47–49]. 
(ii) Sequence-independent amplification.  Sequence-    
independent amplification is the important step in viral 
metagenomics that shows the true genetic composition of 
the sample and simultaneously amplifies several viral ge-
nomes and makes them available, including highly diver-
gent and completely novel viruses, for characterization 
[11,34]. SISPA, random PCR amplification, displacement 
amplification, arbitrarily primed PCR, and rolling circle 
amplification are typically used for sequence-independent 
amplification. Detailed descriptions of these methods have 
been made available in previously published papers [11,50]. 
(iii) High-throughput sequencing.  To identify known, 
highly divergent, or new viruses, sequencing is often uti-
lized. The Sanger sequencing method can create high-quality 
sequence reads up to nearly 1000 nt; however, this highly 
laborious process limits its usage [43]. High-throughput 
sequencing, or NGS, is used more and more often in viral 
metagenomics. The 454 sequencing platform (Roche diag-
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nostics) [8,51], SOLiD sequencing (Life Technologies) 
[7,52], Illumina sequencing [7,52], Helicos sequencing 
(Helicos Biosciences), PacBio sequencing (Pacific Biosci-
ences), and Ion Torrent (Life Technologies) [7,52] are all 
commercial instruments in the marketplace, and all use 
slightly different methodologies to achieve clonal amplifi-
cation and sequencing. The advantages and disadvantages 
of each of these instruments have been detailed in other 
papers [7,5254]. 
(iv) Bioinformatics.  Post-sequencing, the analysis of 
the vast amount of sequencing data produced, is the chal-
lenging part of viral metagenomics. The datasets from met-
agenomic studies are complicated, and they typically con-
tain a mixture of different species. The genomes in the da-
tasets are usually incomplete, with some cases having only a 
small number of short fragments belonging to each genome. 
There are two approaches that can be used for analysis of 
read data, de novo assembly using software such as Velvet 
[55] and mapping strategies using a mapper such as BWA 
[56]. Other programs and platforms also have been devel-
oped, the details of which can be found in the NGS review 
by Blomstrom et al. [50]. 
4  Viruses discovered in human feces 
Feces comprise a community of many different microor-
ganisms, including bacteria and viruses. Many viral diseases 
are transmitted by the oral-fecal route, and the viral agents 
are excreted in the feces. With the development of modern 
molecular methods and viral metagenomics, several new 
viruses have been discovered in feces in the past decade. 
(i) Picornaviruses.  Enteroviruses constitute the largest 
genus within the family Picornaviridae, which have non-     
enveloped, positive-sense, single-stranded RNA (+ssRNA) 
genomes surrounded by four structural proteins, VP1-VP4. 
A majority of these viruses infect humans and cause diseas-
es ranging from minor respiratory illness to severe neuro-
logical disorders like meningitis, encephalitis, and poliomy-
elitis [57]. Metagenomic analyses of viruses in stool sam-
ples from children with acute flaccid paralysis (AFP) found 
numerous viruses, particularly HEV-C, including one from 
a potentially novel enterovirus genotype [58]. 
Human cosavirus (HCoSV) is a proposed new genus in 
the family Picornaviridae originally identified in 2008 in 
feces [59]. Since then, HCoSVs have been detected in feces 
from Australian [60] and Chinese [61] children. HCoSV 
infection with accompanying diarrhea in Thailand [62], the 
prevalence of a new species (F) of HCoSV, and another 26 
new HCoSV genotypes in human feces of healthy children 
and children with AFP [63] were also reported. HCoSV 
pathogenicity in humans has remained unknown because 
detection rates in patients and healthy controls were similar 
in the only available cohort studies of patients with AFP in 
Asia [59] and with gastroenteritis in China [61]. In Brazil, 
the 3.6% detection rate in children with gastroenteritis [64] 
was comparable to the 1.8% rate in a cohort study of gas-
troenteritis in China [61]. The large number of HCoSV 
genotypes/serotypes reported indicates that HCoSV infec-
tion is associated with a range of diseases, such as unex-
plained diarrhea, AFP, or others. Future work will focus on 
defining whether HCoSV is a true human pathogen. 
Two other novel picornaviruses have also been described 
since 2008 due to the advent of metagenomics: klassevirus 
[65] and salivirus [66]. The reported association between 
salivirus shedding and diarrhea indicates that such infec-
tions may account for a significant fraction of the unex-
plained cases of diarrhea occurring worldwide. Future stud-
ies to determine a possible link to disease in humans and 
any unique characteristics of the viral life cycle will be re-
quired. Viral culture in human cell lines, especially those 
from the gastrointestinal tract, could be suggestive that the 
virus is competent to replicate in human cells and that hu-
mans could be a bona fide host of klassevirus [65]. Further 
epidemiological screening and serological assays will be 
necessary to understand the diversity within this possible 
genus, the prevalence of these novel viruses, and the age 
range of those susceptible to infection. 
(ii) Parvoviruses.  Parvoviruses are, as their name sug-
gests, small viruses, with a single-stranded DNA genome 
and are widespread pathogens that cause a wide range of 
diseases in humans and animals. Allander et al. [14] first 
reported the discovery of a previously unidentified human 
parvovirus in 2005. From 2009 to 2010, the bocavirus genus 
was expanded to include three additional species of human 
bocaviruses, HBoV2 [67], HBoV3 [68], and HBoV4 [69]. 
HBoV2-4 seems to be found primarily in human stool 
[67–71]. HBoV1 is predominantly a respiratory pathogen, 
whereas HBoV2 and possibly HBoV3 are associated with 
gastroenteritis [67,71]. A variety of signs and symptoms 
have been described in patients with HBoV infection, in-
cluding rhinitis, pharyngitis, cough, dyspnea, and diarrhea, 
among others [72]. 
Human parvovirus 4 (PARV4) was identified in 2005 in a 
plasma sample [73]. Another two novel parvoviruses closely 
related to PARV4, porcine hokovirus and bovine hokovirus, 
were discovered in feces specimens from Hong Kong [74]. 
Furthermore, a proposed new Parvoviridae genus associated 
with acute diarrhea has been identified; however, wider 
geographic sampling of human and animal fecal samples 
will provide a better understanding of the genetic diversity 
of this proposed genus. Serological assays and case-   
control studies will also help determine whether members of 
this viral clade are associated with diarrhea or other symp-
toms [75]. 
(iii) Astroviruses.  The family Astroviridae consists of 
small, non-lipid enveloped, single-stranded, positive-sense 
RNA viruses with genomes that contain three open reading 
frames (ORFs), designated ORF1a, ORF1b, and ORF2. 
Astroviruses are known to infect a variety of human and 
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animal hosts. Recently, two highly divergent members of 
the astrovirus family, MLB1 [76–78] and VA1 [79], were 
identified and associated with human viral diarrhea. Astro-
viruses VA2, MLB2, and VA3 were also reported as novel 
astroviruses in human stool [80], as was HMOAstV A-C 
[81]. With the rising number of human astrovirus species 
detected in infections associated with unexplained AFP 
and/or diarrhea, increased understanding of the genetic di-
versity within viral families infecting humans will assist in 
future studies of their pathogenicity and allow the design of 
specific diagnostic assays [81]. 
(iv) Polyomaviruses.  Viruses in the Polyomaviridae 
family typically possess ~5000 bp of circular, double-      
stranded DNA. The genome can be divided into three parts, 
including the regulatory region, the early region, and the 
later region. Over the past five years, seven novel polyoma-
viruses have been discovered in humans, namely KI poly-
omavirus (KIPyV) [82], WU polyomavirus (WUPyV) [83], 
Merkel cell polyomavirus (MCPyV) [84], human polyoma-
virus 6 (HPyV-6), human polyomavirus 7 (HPyV-7) [85], 
human polyomavirus 9 (HPyV-9) [86], and trichodysplasia 
spinulosa-associated polyomavirus (TSPyV) [87]. In 2012, 
another two novel polyomaviruses were discovered in hu-
man stool and provisionally named MW polyomavirus 
(MWPyV) [88] and MX polyomavirus (MXPyV) [89]. The 
number of polyomaviruses found in the human body con-
tinues to grow, raising the question of how many more spe-
cies have yet to be identified and what roles they play in 
humans with and without manifest disease. Taking MWPyV 
as an example, one critical question is whether MWPyV is a 
bona fide infectious agent of humans and, if so, which dis-
ease(s), if any, might be associated with MWPyV infection. 
The detection of MWPyV in feces of children with diarrhea, 
many of which are unexplained, raises the possibility that 
MWPyV might play a role in human diarrhea. It is also pos-
sible that MWPyV is a dietary contaminant and does not 
actively infect humans. Serological studies and antibody-     
based immune responses to MWPyV and wider sampling 
and screening are approaches to determine whether 
MWPyV is a true infectious agent [88]. 
(v) Circoviruses.  Members of the family Circoviridae 
are non-enveloped, spherical viruses with a single-stranded 
circular DNA genome of approximately 2 kb––the smallest 
known autonomously replicating viral genome [90]––and 
include the genera circovirus, gyrovirus, and gyclovirus 
(proposed) [91,92]. Until recently, chicken anemia virus 
(CAV) was the only known representative of the gyrovirus 
genus. In the last two years, three novel gyroviruses have 
been reported: avian gyrovirus 2 (AGV2) in chickens [93], a 
human gyrovirus (HGV) detected on human skin [94], and 
gyrovirus 3 (GyV3) in human feces and chicken meat [95]. 
Recently, a novel gyrovirus 4 (GyV4) was also identified in 
human stool and in chicken meat prepared for human con-
sumption [96]. In addition, a new strain of CAV, designated 
GD-1-12, was isolated from fecal samples of a 12-day-old 
commercial broiler in Guangdong province, China [97]. 
Multiple diverse circoviruses were found in human and 
chimpanzee feces, such as CyCV-PK5006 and Chimp 17 
[92]. Other novel single-stranded, circular DNA viruses also 
detected were found in porcine [98] and bovine feces [99], 
respectively. 
Diarrhea is the third leading infectious cause of death 
worldwide, and an estimated 1.4 billion nonfatal episodes 
occur yearly [100,101]. Importantly, it is estimated that 
40% of diarrhea cases are of unknown etiology [60,102]. 
Viral metagenomics has largely propelled the progress in 
virus discovery; however, the association of these newly-    
discovered viruses with specific diseases is largely un-
known. An understanding of these newly-discovered   
viruses’ disease associations and causations is extremely 
urgent.  
5  Metagenomic Koch’s postulates 
Viral metagenomics has provided a powerful tool for dis-
covering new viruses. However, virus discovery is only the 
first step to determining the etiology behind a disease. The 
detection of nucleic acid is not sufficient to prove causality. 
For that, more comprehensive studies have to be performed 
[103]. Evidence for causality is not always conclusive, even 
when the suspect virus is found “at the scene of the crime”. 
This means that finding a virus in a sample from a patient 
with an illness of unknown etiology, and even demonstrat-
ing an association, does not always prove causation. There-
fore, strict guidelines proposed by Robert Koch and later 
modified by Rivers [104] have been used to assign causality 
to infectious agents [10]. One of Koch’s postulates requires 
that the candidate etiological agent be isolated from a dis-
eased organism and grown in pure culture. However, not all 
viruses can be propagated by current culture methods [103].  
In many cases, Koch’s postulates will not be satisfied if 
current culture standards are used to prove causality. Koch’s 
postulates have since been modified to acknowledge molec-
ular methods used to monitor the role played by genes in 
bacterial virulence [105]. The revised so-called molecular 
Koch’s postulates can be applied to pathogenic members of 
a genus or pathogenic strains of a species as well as non-
pathogenic strains. Because genes can be expressed at dif-
ferent time points during infection, however, new molecular 
methods do not always distinctively characterize virulence 
genes and make a clear association with the disease of un-
known etiology. Mokili et al. [10] proposed the so-called 
metagenomic Koch’s postulates, which focus on the identi-
fication of metagenomic traits in disease subjects (Figure 3). 
Molecular markers such as sequence reads, assembled con-
tigs, genes, or full genomes that can uniquely distinguish 
disease-associated metagenomes from those obtained from 
matched healthy control subjects can all be used to define 
metagenomic traits. Thus, satisfying metagenomic Koch’s  
 Xie G C, et al.   Sci China Life Sci   August (2013) Vol.56 No.8 693 
 
Figure 3  Flow chart of virus discovery, pathogenicity determination, intervention, and metagenomic Koch’s postulates. Traits A, D, E, and J found in the 
diseased animal (e.g., a mouse) are not present in the healthy control (represented in blue). The acquisition or increase of new metagenomic traits, A, P, and 
E, are represented in orange. Inoculation of the suspected purified traits into a healthy mouse will induce disease if the traits encompass the etiology of the 
disease (represented in purple); pathogenicity as a trait is represented in red. The figure is modified from models proposed by Mokili et al. [10] and Delwart 
[106]. 
 
Figure 4  The global aviation network. Lines show direct links between airports, and the color of the line indicates passenger capacity in people per day 
(thousands (red), hundreds (yellow), and tens (blue)) [110].  
postulates is possible when one or multiple viral agents are 
involved in disease causation. 
6  Challenges in virus discovery 
Novel viruses are still emerging. In November 2011, a novel 
orthobunyavirus named Schmallenberg virus (SBV) was 
detected in plasma samples from a farm near the German 
town of Schmallenberg by using a metagenomic approach 
with NGS [107]; this novel virus is on the rise in Europe 
[108,109]. The SBV epidemic showed once again that the 
novel technology of metagenomics is very useful for early 
detection of novel pathogens in livestock. In fact, veterinary 
diagnostics in Europe has proved to be a very effective 
network of institutions studying epizootic diseases. Before 
any strategy is decided for prediction, precaution, and pre-
vention of EIDs in humans, three questions should always 
be asked and answered: what to expect, what to be prepared 
for, and what to do. 
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Figure 5  The discovery curve for human virus species. The cumulative 
number of species reported to infect humans (black circles and line). Sta-
tistically significant upward breakpoints are shown (vertical lines). The 
best-fit curve (solid line) and lower and upper 95% posterior intervals 
(dashed lines) for extrapolation to 2020 are shown [115]. 
Another important issue is that of emerging vector-borne 
diseases in global health. Many vector-borne pathogens 
have appeared in new regions in the past two decades. An-
thropogenic trade, travel, as well as hosts, vectors, and cli-
mate conditions all contribute to emerging vector-borne 
disease. Figure 4 shows the direct links between airports 
spanning across the world. Knowing the drivers, dynamics, 
and ecology of zoonoses are all helpful for prediction and 
prevention of the next pandemic zoonosis [110–112]. 
The Virus Pathogen Database and Analysis Resource 
(ViPR; www.ViPRbrc.org) is an integrated repository of 
data and analysis tools for multiple virus families and is 
supported by the National Institute of Allergy and Infectious 
Diseases (NIAID) Bioinformatics Resource Centers (BRC) 
program. This program has the advantage of a powerful 
suite of resources provided by the ViPR BRC with which 
virology researchers can streamline and expedite experi-
mental discovery for the ultimate goal of developing im-
proved diagnostics, prophylactics, and/or therapeutics for 
pathogenic viruses [113,114]. With globally coordinated 
activity and effort, temporal trends in the discovery of hu-
man viruses [115] (Figure 5) will enable the control of 




1 Fouchier R A, Kuiken T, Schutten M, et al. Aetiology: Koch’s pos-
tulates fulfilled for SARS virus. Nature, 2003, 423: 240 
2 Drosten C, Gunther S, Preiser W, et al. Identification of a novel 
coronavirus in patients with severe acute respiratory syndrome. N 
Engl J Med, 2003, 348: 1967–1976 
3 Marra M A, Jones S J, Astell C R, et al. The Genome sequence of 
the SARS-associated coronavirus. Science, 2003, 300: 1399–1404 
4 Peiris J S, Guan Y, Yuen K Y. Severe acute respiratory syndrome. 
Nat Med, 2004, 10: S88–S97 
5 Rota P A, Oberste M S, Monroe S S, et al. Characterization of a 
novel coronavirus associated with severe acute respiratory syndrome. 
Science, 2003, 300: 1394–1399 
6 Reyes G R, Kim J P. Sequence-independent, single-primer amplifi-
cation (SISPA) of complex DNA populations. Mol Cell Probes, 
1991, 5: 473–481 
7 Radford A D, Chapman D, Dixon L, et al. Application of next-      
generation sequencing technologies in virology. J Gen Virol, 2012, 
93: 1853–1868 
8 Margulies M, Egholm M, Altman W E, et al. Genome sequencing in 
microfabricated high-density picolitre reactors. Nature, 2005, 437: 
376–380 
9 Rosario K, Breitbart M. Exploring the viral world through meta-
genomics. Curr Opin Virol, 2011, 1: 289–297 
10 Mokili J L, Rohwer F, Dutilh B E. Metagenomics and future per-
spectives in virus discovery. Curr Opin Virol, 2012, 2: 63–77 
11 Delwart E L. Viral metagenomics. Rev Med Virol, 2007, 17: 115– 
131 
12 Yu X J, Liang M F, Zhang S Y, et al. Fever with thrombocytopenia 
associated with a novel bunyavirus in China. N Engl J Med, 2011, 
364: 1523–1532 
13 Wu Y, Gao G F. Severe fever with thrombocytopenia syndrome vi-
rus expands its borders. Emerg Microbes Infect, 2013, in press 
14 Allander T, Tammi M T, Eriksson M, et al. Cloning of a human 
parvovirus by molecular screening of respiratory tract samples. Proc 
Natl Acad Sci USA, 2005, 102: 12891–12896 
15 Zaki A M, van Boheemen S, Bestebroer T M, et al. Isolation of a 
novel coronavirus from a man with pneumonia in Saudi Arabia. N 
Engl J Med, 2012, 367: 1814–1820 
16 van Boheemen S, de Graaf M, Lauber C, et al. Genomic characteri-
zation of a newly discovered coronavirus associated with acute res-
piratory distress syndrome in humans. MBio, 2012, 3: e00473–12 
17 Chan J F, Li K S, To K K, et al. Is the discovery of the novel human 
betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of an-
other SARS-like pandemic? J Infect, 2012, 65: 477–489 
18 Mullis K, Faloona F, Scharf S, et al. Specific enzymatic amplifica-
tion of DNA in vitro: the polymerase chain reaction. Cold Spring 
Harb Symp Quant Biol, 1986, 51(Pt 1): 263–273 
19 Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain-    
terminating inhibitors. Proc Natl Acad Sci USA, 1977, 74: 5463– 
5467 
20 Benson D A, Karsch-Mizrachi I, Lipman D J, et al. GenBank. Nu-
cleic Acids Res, 2011, 39: D32–D37 
21 Murray K, Selleck P, Hooper P, et al. A morbillivirus that caused 
fatal disease in horses and humans. Science, 1995, 268: 94–97 
22 Chua K B, Bellini W J, Rota P A, et al. Nipah virus: a recently 
emergent deadly paramyxovirus. Science, 2000, 288: 1432–1435 
23 Philbey A W, Kirkland P D, Ross A D, et al. An apparently new vi-
rus (family Paramyxoviridae) infectious for pigs, humans, and fruit 
bats. Emerg Infect Dis, 1998, 4: 269–271 
24 Chua K B, Crameri G, Hyatt A, et al. A previously unknown reovi-
rus of bat origin is associated with an acute respiratory disease in 
humans. Proc Natl Acad Sci USA, 2007, 104: 11424–11429 
25 Barrette R W, Metwally S A, Rowland J M, et al. Discovery of 
swine as a host for the Reston ebolavirus. Science, 2009, 325: 
204–206 
26 Mokili J L, Rogers M, Carr J K, et al. Identification of a novel clade 
of human immunodeficiency virus type 1 in Democratic Republic of 
Congo. AIDS Res Hum Retroviruses, 2002, 18: 817–823 
27 Takemura T, Ekwalanga M, Bikandou B, et al. A novel simian im-
munodeficiency virus from black mangabey (Lophocebus aterrimus) 
in the Democratic Republic of Congo. J Gen Virol, 2005, 86: 1967– 
1971 
28 Barlow K L, Ajao A O, Clewley J P. Characterization of a novel 
simian immunodeficiency virus (SIVmonNG1) genome sequence 
from a mona monkey (Cercopithecus mona). J Virol, 2003, 77: 
6879–6888 
29 Clewley J P, Lewis J C, Brown D W, et al. A novel simian immu-
nodeficiency virus (SIVdrl) pol sequence from the drill monkey, 
Mandrillus leucophaeus. J Virol, 1998, 72: 10305–10309 
30 Reyes G R, Purdy M A, Kim J P, et al. Isolation of a cDNA from the 
virus responsible for enterically transmitted non-A, non-B hepatitis. 
Science, 1990, 247: 1335–1339 
31 Chou C C, Lee T T, Chen C H, et al. Design of microarray probes 
for virus identification and detection of emerging viruses at the ge-
 Xie G C, et al.   Sci China Life Sci   August (2013) Vol.56 No.8 695 
nus level. BMC Bioinformatics, 2006, 7: 232 
32 Nicholson T L, Kukielka D, Vincent A L, et al. Utility of a panviral 
microarray for detection of swine respiratory viruses in clinical sam-
ples. J Clin Microbiol, 2011, 49: 1542–1548 
33 Yozwiak N L, Skewes-Cox P, Stenglein M D, et al. Virus identifica-
tion in unknown tropical febrile illness cases using deep sequencing. 
PLoS Negl Trop Dis, 2012, 6: e1485 
34 Bexfield N, Kellam P. Metagenomics and the molecular identifica-
tion of novel viruses. Vet J, 2011, 190: 191–198 
35 Finkbeiner S R, Li Y, Ruone S, et al. Identification of a novel astro-
virus (astrovirus VA1) associated with an outbreak of acute gastro-
enteritis. J Virol, 2009, 83: 10836–10839 
36 Allander T, Emerson S U, Engle R E, et al. A virus discovery meth-
od incorporating DNase treatment and its application to the identifi-
cation of two bovine parvovirus species. Proc Natl Acad Sci USA, 
2001, 98: 11609–11614 
37 Handelsman J, Rondon M R, Brady S F, et al. Molecular biological 
access to the chemistry of unknown soil microbes: a new frontier for 
natural products. Chem Biol, 1998, 5: R245–R249 
38 Riesenfeld C S, Schloss P D, Handelsman J. Metagenomics: ge-
nomic analysis of microbial communities. Annu Rev Genet, 2004, 
38: 525–552 
39 Schloss P D, Handelsman J. Biotechnological prospects from meta-
genomics. Curr Opin Biotechnol, 2003, 14: 303–310 
40 Breitbart M, Salamon P, Andresen B, et al. Genomic analysis of un-
cultured marine viral communities. Proc Natl Acad Sci USA, 2002, 
99: 14250–14255 
41 Thurber R V, Haynes M, Breitbart M, et al. Laboratory procedures 
to generate viral metagenomes. Nat Protoc, 2009, 4: 470–483 
42 Edwards R A, Rodriguez-Brito B, Wegley L, et al. Using pyrose-
quencing to shed light on deep mine microbial ecology. BMC Ge-
nomics, 2006, 7: 57 
43 Breitbart M, Rohwer F. Method for discovering novel DNA viruses 
in blood using viral particle selection and shotgun sequencing. Bio-
techniques, 2005, 39: 729–736 
44 Willner D, Furlan M, Schmieder R, et al. Metagenomic detection of 
phage-encoded platelet-binding factors in the human oral cavity. 
Proc Natl Acad Sci USA, 2011, 108(Suppl 1): 4547–4553 
45 Endoh D, Mizutani T, Kirisawa R, et al. Species-independent detec-
tion of RNA virus by representational difference analysis using 
non-ribosomal hexanucleotides for reverse transcription. Nucleic 
Acids Res, 2005, 33: e65 
46 Armour C D, Castle J C, Chen R, et al. Digital transcriptome profil-
ing using selective hexamer priming for cDNA synthesis. Nat 
Methods, 2009, 6: 647–649 
47 He S, Wurtzel O, Singh K, et al. Validation of two ribosomal RNA 
removal methods for microbial metatranscriptomics. Nat Methods, 
2010, 7: 807–812 
48 Stewart F J, Ottesen E A, DeLong E F. Development and quantita-
tive analyses of a universal rRNA-subtraction protocol for microbial 
metatranscriptomics. ISME J, 2010, 4: 896–907 
49 Chen Z, Duan X. Ribosomal RNA depletion for massively parallel 
bacterial RNA-sequencing applications. Methods Mol Biol, 2011, 
733: 93–103 
50 Blomstrom A L. Viral metagenomics as an emerging and powerful 
tool in veterinary medicine. Vet Q, 2011, 31: 107–114 
51 Gilles A, Meglecz E, Pech N, et al. Accuracy and quality assessment 
of 454 GS-FLX Titanium pyrosequencing. BMC Genomics, 2011, 
12: 245 
52 Loman N J, Misra R V, Dallman T J, et al. Performance comparison 
of benchtop high-throughput sequencing platforms. Nat Biotechnol, 
2012, 30: 434–439 
53 Quail M A, Smith M, Coupland P, et al. A tale of three next genera-
tion sequencing platforms: comparison of Ion Torrent, Pacific Bio-
sciences and Illumina MiSeq sequencers. BMC Genomics, 2012, 13: 
341 
54 Liu L, Li Y, Li S, et al. Comparison of next-generation sequencing 
systems. J Biomed Biotechnol, 2012, 2012: 251364 
55 Zerbino D R, Birney E. Velvet: algorithms for de novo short read 
assembly using de Bruijn graphs. Genome Res, 2008, 18: 821–829 
56 Li H, Durbin R. Fast and accurate short read alignment with Bur-
rows-Wheeler transform. Bioinformatics, 2009, 25: 1754–1760 
57 Berlin L E, Rorabaugh M L, Heldrich F, et al. Aseptic meningitis in 
infants <2 years of age: diagnosis and etiology. J Infect Dis, 1993, 
168: 888–892 
58 Victoria J G, Kapoor A, Li L, et al. Metagenomic analyses of viruses 
in stool samples from children with acute flaccid paralysis. J Virol, 
2009, 83: 4642–4651 
59 Kapoor A, Victoria J, Simmonds P, et al. A highly prevalent and 
genetically diversified Picornaviridae genus in South Asian children. 
Proc Natl Acad Sci USA, 2008, 105: 20482–20487 
60 Holtz L R, Finkbeiner S R, Kirkwood C D, et al. Identification of a 
novel picornavirus related to cosaviruses in a child with acute diar-
rhea. Virol J, 2008, 5: 159 
61 Dai X Q, Hua X G, Shan T L, et al. Human cosavirus infections in 
children in China. J Clin Virol, 2010, 48: 228–229 
62 Khamrin P, Chaimongkol N, Malasao R, et al. Detection and molec-
ular characterization of cosavirus in adults with diarrhea, Thailand. 
Virus Genes, 2012, 44: 244–246 
63 Kapusinszky B, Phan T G, Kapoor A, et al. Genetic diversity of the 
genus Cosavirus in the family Picornaviridae: a new species, recom-
bination, and 26 new genotypes. PLoS ONE, 2012, 7: e36685 
64 Stocker A, Souza B F, Ribeiro T C, et al. Cosavirus infection in 
persons with and without gastroenteritis, Brazil. Emerg Infect Dis, 
2012, 18: 656–659 
65 Greninger A L, Runckel C, Chiu C Y, et al. The complete genome of 
klassevirus––a novel picornavirus in pediatric stool. Virol J, 2009, 6: 
82 
66 Li L, Victoria J, Kapoor A, et al. A novel picornavirus associated 
with gastroenteritis. J Virol, 2009, 83: 12002–12006 
67 Arthur J L, Higgins G D, Davidson G P, et al. A novel bocavirus 
associated with acute gastroenteritis in Australian children. PLoS 
Pathog, 2009, 5: e1000391 
68 Kapoor A, Slikas E, Simmonds P, et al. A newly identified bo-
cavirus species in human stool. J Infect Dis, 2009, 199: 196–200 
69 Kapoor A, Simmonds P, Slikas E, et al. Human bocaviruses are 
highly diverse, dispersed, recombination prone, and prevalent in en-
teric infections. J Infect Dis, 2010, 201: 1633–1643 
70 Chieochansin T, Kapoor A, Delwart E, et al. Absence of detectable 
replication of human bocavirus species 2 in respiratory tract. Emerg 
Infect Dis, 2009, 15: 1503–1505 
71 Chow B D, Ou Z, Esper F P. Newly recognized bocaviruses (HBoV, 
HBoV2) in children and adults with gastrointestinal illness in the 
United States. J Clin Virol, 2010, 47: 143–147 
72 Jartti T, Hedman K, Jartti L, et al. Human bocavirus––the first 5 
years. Rev Med Virol, 2012, 22: 46–64 
73 Jones M S, Kapoor A, Lukashov V V, et al. New DNA viruses iden-
tified in patients with acute viral infection syndrome. J Virol, 2005, 
79: 8230–8236 
74 Lau S K, Woo P C, Tse H, et al. Identification of novel porcine and 
bovine parvoviruses closely related to human parvovirus 4. J Gen 
Virol, 2008, 89: 1840–1848 
75 Phan T G, Vo N P, Bonkoungou I J, et al. Acute diarrhea in West 
African children: diverse enteric viruses and a novel parvovirus ge-
nus. J Virol, 2012, 86: 11024–11030 
76 Finkbeiner S R, Allred A F, Tarr P I, et al. Metagenomic analysis of 
human diarrhea: viral detection and discovery. PLoS Pathog, 2008, 4: 
e1000011 
77 Finkbeiner S R, Kirkwood C D, Wang D. Complete genome se-
quence of a highly divergent astrovirus isolated from a child with 
acute diarrhea. Virol J, 2008, 5: 117 
78 Finkbeiner S R, Le B M, Holtz L R, et al. Detection of newly de-
scribed astrovirus MLB1 in stool samples from children. Emerg In-
fect Dis, 2009, 15: 441–444 
79 Finkbeiner S R, Li Y, Ruone S, et al. Identification of a novel astro-
virus (astrovirus VA1) associated with an outbreak of acute gastro-
enteritis. J Virol, 2009, 83: 10836–10839 
80 Finkbeiner S R, Holtz L R, Jiang Y, et al. Human stool contains a 
696 Xie G C, et al.   Sci China Life Sci   August (2013) Vol.56 No.8 
previously unrecognized diversity of novel astroviruses. Virol J, 
2009, 6: 161 
81 Kapoor A, Li L, Victoria J, et al. Multiple novel astrovirus species in 
human stool. J Gen Virol, 2009, 90: 2965–2972 
82 Allander T, Andreasson K, Gupta S, et al. Identification of a third 
human polyomavirus. J Virol, 2007, 81: 4130–4136 
83 Gaynor A M, Nissen M D, Whiley D M, et al. Identification of a 
novel polyomavirus from patients with acute respiratory tract infec-
tions. PLoS Pathog, 2007, 3: e64 
84 Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyoma-
virus in human Merkel cell carcinoma. Science, 2008, 319: 1096–1100 
85 Schowalter R M, Pastrana D V, Pumphrey K A, et al. Merkel cell 
polyomavirus and two previously unknown polyomaviruses are 
chronically shed from human skin. Cell Host Microbe, 2010, 7: 
509–515 
86 Scuda N, Hofmann J, Calvignac-Spencer S, et al. A novel human 
polyomavirus closely related to the african green monkey-derived 
lymphotropic polyomavirus. J Virol, 2011, 85: 4586–4590 
87 van der Meijden E, Janssens R W, Lauber C, et al. Discovery of a 
new human polyomavirus associated with trichodysplasia spinulosa 
in an immunocompromized patient. PLoS Pathog, 2010, 6: 
e1001024 
88 Siebrasse E A, Reyes A, Lim E S, et al. Identification of MW poly-
omavirus, a novel polyomavirus in human stool. J Virol, 2012, 86: 
10321–10326 
89 Yu G, Greninger A L, Isa P, et al. Discovery of a novel polyoma-
virus in acute diarrheal samples from children. PLoS ONE, 2012, 7: 
e49449 
90 Fringuelli E, Scott A N, Beckett A, et al. Diagnosis of duck circovirus 
infections by conventional and real-time polymerase chain reaction 
tests. Avian Pathol, 2005, 34: 495–500 
91 Blinkova O, Victoria J, Li Y, et al. Novel circular DNA viruses in 
stool samples of wild-living chimpanzees. J Gen Virol, 2010, 91: 
74–86 
92 Li L, Kapoor A, Slikas B, et al. Multiple diverse circoviruses infect 
farm animals and are commonly found in human and chimpanzee 
feces. J Virol, 2010, 84: 1674–1682 
93 Rijsewijk F A, Dos S H, Teixeira T F, et al. Discovery of a genome 
of a distant relative of chicken anemia virus reveals a new member 
of the genus Gyrovirus. Arch Virol, 2011, 156: 1097–1100 
94 Sauvage V, Cheval J, Foulongne V, et al. Identification of the first 
human gyrovirus, a virus related to chicken anemia virus. J Virol, 
2011, 85: 7948–7950 
95 Phan T G, Li L, O'Ryan M G, et al. A third gyrovirus species in hu-
man faeces. J Gen Virol, 2012, 93: 1356–1361 
96 Chu D K, Poon L L, Chiu S S, et al. Characterization of a novel gy-
rovirus in human stool and chicken meat. J Clin Virol, 2012, 55: 
209–213 
97 Zhang X, Xie Q, Ji J, et al. Complete genome sequence analysis of a 
recent chicken anemia virus isolate and comparison with a chicken 
anemia virus isolate from human fecal samples in China. J Virol, 
2012, 86: 10896–10897 
98 Sikorski A, Arguello-Astorga G R, Dayaram A, et al. Discovery of a 
novel circular single-stranded DNA virus from porcine faeces. Arch 
Virol, 2013, 158: 283–289 
99 Kim H K, Park S J, Nguyen V G, et al. Identification of a novel sin-
gle-stranded, circular DNA virus from bovine stool. J Gen Virol, 
2012, 93: 635–639 
100 Kosek M, Bern C, Guerrant R L. The global burden of diarrhoeal 
disease, as estimated from studies published between 1992 and 2000. 
Bull World Health Organ, 2003, 81: 197–204 
101 O’'Ryan M, Prado V, Pickering L K. A millennium update on pedi-
atric diarrheal illness in the developing world. Semin Pediatr Infect 
Dis, 2005, 16: 125–136 
102 Denno D M, Stapp J R, Boster D R, et al. Etiology of diarrhea in pe-
diatric outpatient settings. Pediatr Infect Dis J, 2005, 24: 142–148 
103 Fredericks D N, Relman D A. Sequence-based identification of mi-
crobial pathogens: a reconsideration of Koch's postulates. Clin Mi-
crobiol Rev, 1996, 9: 18–33 
104 Rivers T M. Viruses and Koch’s Postulates. J Bacteriol, 1937, 33: 
1–12 
105 Falkow S. Molecular Koch’s postulates applied to microbial patho-
genicity. Rev Infect Dis, 1988, 10(Suppl 2): S274–S276 
106 Delwart E. Animal virus discovery: improving animal health, under-
standing zoonoses, and opportunities for vaccine development. Curr 
Opin Virol, 2012, 2: 344–352 
107 Hoffmann B, Scheuch M, Hoper D, et al. Novel orthobunyavirus in 
Cattle, Europe, 2011. Emerg Infect Dis, 2012, 18: 469–472 
108 Garigliany M M, Bayrou C, Kleijnen D, et al. Schmallenberg virus: 
a new Shamonda/Sathuperi-like virus on the rise in Europe. Antivi-
ral Res, 2012, 95: 82–87 
109 Beer M, Conraths F J, van der Poel W H. ‘Schmallenberg virus’––a 
novel orthobunyavirus emerging in Europe. Epidemiol Infect, 2013, 
141: 1–8 
110 Kilpatrick A M, Randolph S E. Drivers, dynamics, and control of 
emerging vector-borne zoonotic diseases. Lancet, 2012, 380: 1946– 
1955 
111 Morse S S, Mazet J A, Woolhouse M, et al. Prediction and preven-
tion of the next pandemic zoonosis. Lancet, 2012, 380: 1956–1965 
112 Karesh W B, Dobson A, Lloyd-Smith J O, et al. Ecology of zoono-
ses: natural and unnatural histories. Lancet, 2012, 380: 1936–1945 
113 Pickett B E, Greer D S, Zhang Y, et al. Virus pathogen database and 
analysis resource (ViPR): a comprehensive bioinformatics database 
and analysis resource for the coronavirus research community. Vi-
ruses, 2012, 4: 3209–3226 
114 Pickett B E, Sadat E L, Zhang Y, et al. ViPR: an open bioinformatics 
database and analysis resource for virology research. Nucleic Acids 
Res, 2012, 40: D593–D598 
115 Woolhouse M E, Howey R, Gaunt E, et al. Temporal trends in the 
discovery of human viruses. Proc Biol Sci, 2008, 275: 2111–2115 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
 
